Disruption of IFNγ, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8+ T Cells.
Chakrapani VemulawadaPranav S RenavikarMichael P CrawfordScott Steward-TharpNitin J KarandikarPublished in: Journal of immunology (Baltimore, Md. : 1950) (2024)
An imbalance between proinflammatory and regulatory processes underlies autoimmune disease pathogenesis. We have shown that acute relapses of multiple sclerosis are characterized by a deficit in the immune suppressive ability of CD8+ T cells. These cells play an important immune regulatory role, mediated in part through cytotoxicity (perforin [PRF]/granzyme [GZM]) and IFNγ secretion. In this study, we further investigated the importance of IFNγ-, GZMB-, PRF1-, and LYST-associated pathways in CD8+ T cell-mediated suppression. Using the CRISPR-Cas9 ribonucleoprotein transfection system, we first optimized efficient gene knockout while maintaining high viability in primary bulk human CD8+ T cells. Knockout was confirmed through quantitative real-time PCR assays in all cases, combined with flow cytometry where appropriate, as well as confirmation of insertions and/or deletions at genomic target sites. We observed that the knockout of IFNγ, GZMB, PRF1, or LYST, but not the knockout of IL4 or IL5, resulted in significantly diminished in vitro suppressive ability in these cells. Collectively, these results reveal a pivotal role for these pathways in CD8+ T cell-mediated immune suppression and provide important insights into the biology of human CD8+ T cell-mediated suppression that could be targeted for immunotherapeutic intervention.
Keyphrases
- endothelial cells
- multiple sclerosis
- crispr cas
- immune response
- induced apoptosis
- dendritic cells
- flow cytometry
- induced pluripotent stem cells
- randomized controlled trial
- pluripotent stem cells
- cell cycle arrest
- genome editing
- genome wide
- real time pcr
- gene expression
- oxidative stress
- mass spectrometry
- liver failure
- signaling pathway
- endoplasmic reticulum stress
- high throughput
- drug delivery
- single molecule
- cancer therapy
- aortic dissection